Sekhmet Pharmaventures Boosts Senior Management

• Company appointed seasoned industry leaders as new Chief Commercial Officer and Chief Human Resources Officer
• Over 25% EBITDA growth achieved over the first 8 months in FY26
• Integrating API and CDMO capabilities helped increase global customer confidence

Mumbai, January 08, 2026 – PAG-led Sekhmet Pharmaventures announced today that it has appointed two seasoned industry leaders, Sumit Kumar as Chief Commercial Officer (CCO) and Jitendra Jalan as Chief Human Resources Officer (CHRO), to support its next phase of global expansion.

These new appointments further reinforce Sekhmet’s strategic emphasis on scaling its fully integrated API and CDMO platform while building a strong, future-ready organization anchored in people, capability and performance.

Sekhmet has seen strong business momentum in FY26 under its new leadership. The strategic focus on integrating its API and CDMO capabilities has resulted in increased global customer confidence. The company has recorded more than 25% EBITDA growth over the first 8 months of FY26, signalling a strong trajectory for the current fiscal year.

Sumit Kumar (CCO) brings over 24 years of experience across APIs, formulations, and international regulatory environments. His deep expertise spans in regulatory issue management, product lifecycle oversight, intellectual property, and ESG initiatives. Previously, Sumit spent 15 years at Dr. Reddy’s Laboratories and most recently served as CCO at Cohance Lifesciences, where he drove portfolio expansion, optimized business processes and strengthened customer service standards.

Sumit has extensive international business experience across North America, China, North Asia, MENA and other markets. He holds an MBA and has completed the AMP (Advanced Management Programme) at The Wharton School. At Sekhmet, he will lead business development and export growth strategies, leveraging the company’s integrated platform to expand its presence across regulated and semi-regulated markets.

Jitendra Jalan (CHRO) brings over 25 years of multidisciplinary leadership experience spanning Sales, Operations and Human Resources. He has held senior leadership roles at USV Pvt Ltd, ACC Ltd, Endress+Hauser India, Astral Glass and other leading IT organizations. Jitendra is recognized for driving large-scale organizational transformation, strengthening leadership pipelines to support sustainable business growth.

He holds a PGCHRM from XLRI, is SHRM-SCP certified, and an ICF-ACC accredited coach. At Sekhmet, Jitendra will focus on strategic HR business partnering, leadership development and fostering a high-performance, people-centric culture aligned with the company’s global growth ambitions.

Commenting on the leadership appointments, Santosh Mahil, Managing Director & CEO of Sekhmet, said: “We are thrilled to welcome Jitendra and Sumit to Sekhmet. As a fully integrated API and CDMO platform through Optimus Pharma and Anjan Drug, we are experiencing strong growth across our API and CDMO business. These appointments enhance both our commercial and operational leadership, enabling us to address evolving global customer needs with agility, expertise and sustainability at the core.”

Nikhil Srivastava, Co-head of Private Equity at PAG, added: “We are delighted to welcome Sumit and Jitendra to the Sekhmet’s leadership. The Sekhmet 2.0 transformation program reflects our commitment to solidifying Sekhmet’s industry leading position. We are confident that the new leadership will accelerate Sekhmet’s progress in advancing its CDMO and API businesses.”